Skip to Main Content

Faculty and Staff

  • Assistant Professor; Director, Neurocritical Care Fellowship Program, Neurology

    Rachel Beekman began her medical training in her home state of New York at Stony Brook University School of Medicine but has since relocated to New Haven, where she completed her neurology residency and neurocritical care fellowship at Yale New Haven Hospital. Rachel is the first Yale alumni to continue as faculty in the department of neurocritical care. Rachel has a passion for treating survivors of cardiac arrest and is building a multi-disciplinary cardiac arrest program. In her spare time Rachel loves being mom to her two young boys and spending family time at all the beautiful Connecticut parks.
  • Associate Professor Term; Staff Neurointensivist, Neurology; Director of Clinical Research in Neurocritical Care, Neurology; Training Director, Yale/AHA Bugher Center for Intracerebral Hemorrhage Research, Neurology

    I am a Neurologist with subspecialty training in Neurocritical Care and Stroke, and an Epidemiologist with expertise in Population Genetics and Big Data. While on clinical duties, I treat critically ill patients that have sustained a significant neurological injury due to ischemic stroke, subarachnoid hemorrhage, intraparenchymal hemorrhage, traumatic brain injury, seizures, recent neurosurgery, decompensated neuromuscular diseases, and several others. My research lies at the interphase of clinical neurology, neuroimaging, population genetics and genomic medicine. I am interested in understanding how common and rare genetic variation influences the occurrence, severity, functional outcome and recurrence of stroke, both hemorrhagic and ischemic. Genetic variants influencing these phenotypes can be used for numerous applications, including: (1) identification of novel biological mechanisms involved in causing stroke and determining its severity and outcome, (2) answering non-genetic epidemiological questions using gene mutations as instruments (in the statistical sense of the word), and (3) risk stratification of patients according to their genetic profile. Through the International Stroke Genetics Consortium, I work in close collaboration with numerous investigators interested in stroke genomics from around the world.
  • Associate Professor; Director, Neurosciences Intensive Care Unit, Neurology; Co-director, Neuorotrauma, Neurology & Neurosurgery

    Emily J. Gilmore, MD has been a member of  the Division of Neurocritical Care and Emergency Neurology at the Yale School of Medicine and a neurointensivist and critical care EEG attending at Yale-New Haven Hospital in Connecticut since 2012. Dr. Gilmore completed her neurology residency and 3-year combined fellowship at Columbia University where she fostered a clinical and research interest in neuromonitoring. She was one of the first neurointensivists to become board certified in critical care EEG monitoring and was recruited to Yale to help build a state-of-the art Neuro-ICU where technology could be deployed to deliver cutting edge care for patients with acute brain injury.  Marrying her clinical and research interests was natural; she was an early recipient of the Yale Center for Clinical Investigation (YCCI) Clinical Scholars program and the American Brain Foundation Clinical Research Training Fellowship.  She currently serves as the site-PI for several national neurotrauma trials and was recently awarded her first RO1 with colleagues from MGH and UTSW to link the relationship between biomarkers of secondary brain injury, treatment and outcomes in patients with severe TBI.  Her overarching research interests center on understanding and translating physiologic biomarkers obtained from invasive and noninvasive multimodal brain monitoring to individualize care that will improve outcomes for patients with acute brain injury. Administratively, in addition to her role as Director of the Neuro-ICU and Director of Neuromonitoring, Dr. Gilmore is the co-Director of Neurotrauma. With colleagues in Neurosurgery, she is building a comprehensive multidisciplinary program that addresses the continuum of care needs, from the acute setting though rehabilitation and recovery, for patients with TBI.  Additionally, she is the fellowship director for both Neurocritical Care and Critical Care EEG programs, serves as the vice-chair of the Critical Care EEG Monitoring Research Consortium (CCEMRC) and sits on the scientific advisory board for the NORSE institute.
  • Assistant Professor

    Dr. Kim is a critical care neurologist with expertise in quantitative analysis of critical care electroencephalography and neuroimaging.  Dr. Kim graduated from Brown University for her undergraduate and M.D.-Ph.D. degrees. She completed her residency in Neurology followed by a neurocritical care fellowship at Massachusetts General and Brigham & Women's Hospitals. Dr. Kim is dedicated to advancing the early diagnosis and treatment of patients with devastating neurologic injury who are at highest risk for short and long-term complications.  Dr. Kim is applying novel computational methods to the data gathered within the neurologic intensive care unit to predict patients who are at high risk for further injury. Her ultimate goal is to use these predictions to optimize treatment strategies which prevent these complications.
  • Associate Professor Term; Staff Neurointensivist, Neuroscience Intensive Care Unit

    Nils Petersen obtained his medical degree and a doctorate in neuroscience from Christian-Albrechts University in Kiel, Germany. He completed his residency in Neurology at Mount Sinai Hospital in New York, NY, where he also served as chief resident in his final year. He then pursued fellowship training in Vascular Neurology at Columbia University and simultaneously completed a Master's degree in Patient-Oriented Research at the Mailman School of Public Health. He next completed a fellowship in Neurocritical Care at Massachusetts General Hospital and also obtained certification in Neurovascular Ultrasound from the American Society of Neuroimaging. He is the director of the Yale Cerebral Blood Flow Laboratory, which provides the infrastructure for advanced monitoring of brain physiology. His clinical and research interests are in using ultrasound and novel neuromonitoring modalities to better understand brain blood flow regulation. His ongoing clinical care of patients in the Neurologic Intensive Care Unit and Stroke Service continues to inspire his research pursuits, with the goal of improving patient outcomes and preventing neurologic worsening after acute ischemic stroke.
  • Assistant Professor of Neurology; Affiliated Faculty, Yale Institute for Global Health

    Dr. Prust received his MD from Harvard Medical School. He completed residency training in neurology at Massachusetts General Hospital and Brigham & Women's Hospital, where he served as chief resident in his final year, and completed fellowship training in neurocritical care at New York-Presbyterian Hospital. Dr. Prust is dedicated to providing the best care to patients and their families who are suffering from acute neurologic illnesses such as brain hemorrhage, stroke, seizure, and traumatic brain injury. His research interests lie at the intersection of neurology, critical care, and global health, and he is passionate about finding ways to improve outcomes from neurologic emergencies in resource-limited settings.
  • Professor of Neurology and Neurosurgery; Executive Director of the NNCTU and Vice Chair for Clinical and Translational Research in the Departments of Neurology and Neurosurgery; Division Chief, Neurocritical Care and Emergency Neurology

    Dr. Kevin Sheth is the founding Chief of the Division of Neurocritical Care & Emergency Neurology. His interests are in the advancement of therapies for acute brain injury such as stroke and brain hemorrhage. He is recognized for his leadership in prevention, acute treatment, and recovery.  In pioneering the development of new strategies to treat brain swelling, his work has changed the fundamental approach to brain injury in the ICU and spurned the creation of new technologies in drug delivery and neuroimaging. His team at Yale has served as a national model for academic critical care neurology units. He is currently the principal investigator for two NIH neuroscience networks, NeuroNEXT and StrokeNet, and three additional RO1/UO1 awards from the NIH. Dr. Sheth has served as PI or co-PI for 8 multicenter clinical trials in stroke, as well as chair for clinical endpoint and data safety monitoring committees for several pivotal studies. He is a winner of the prestigious Robert Siekert Award from the American Heart Association (AHA), the Derek Denny Brown Award from the American Neurological Association and an elected member of the American Society for Clinical Investigation (ASCI). His research has been funded by the NIH, American Academy of Neurology, AHA, and the US Army. Dr. Sheth is the author of over 250 publications and has served on study sections for the NIH, AHA, FDA and NASA. He is an Associate Editor at Neurology and on the editorial boards for Stroke and Neurosurgery. His work has been showcased in The Washington Post, Wall Street Journal, NPR, and CNN.   Finally, Dr. Sheth has formed exciting partnerships with entrepreneurs, pharmaceutical companies, and medical device start-ups to bring forward highly innovative solutions. These efforts have resulted in extensive knowledge of FDA pathways, development of phase I-III drug programs, and implementation of new technology into the clinical workspace. The principal theme of his efforts are towards collaboration and an improved understanding of neurological disease.